本页面由Tiger Trade Technology Pte. Ltd.提供服务

Tarsus Pharmaceuticals, Inc.

70.53
-3.8700-5.20%
成交量:58.93万
成交额:4,310.88万
市值:30.95亿
市盈率:-65.16
高:75.02
开:74.50
低:70.43
收:74.40
52周最高:91.53
52周最低:53.89
股本:4,388.30万
流通股本:3,563.83万
量比:0.84
换手率:1.65%
股息:- -
股息率:- -
每股收益(TTM):-1.0824
每股收益(LYR):-1.5900
净资产收益率:-13.68%
总资产收益率:-5.48%
市净率:8.93
市盈率(LYR):-44.36

数据加载中...

2025/03/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/18

重要事件披露

Form 8-K - Current report
2025/03/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities